Hemodialysis with Regional Citrate Anticoagulation, Low-Molecular-weight Heparin, and Heparin-Free Hemodialysis: Efficacy and Safety in Patients at High Risk of Bleeding

Qi TANG,Liming ZHANG,Bibo WU,Hua YU,Yunlan HE

DOI: https://doi.org/10.3969/j.issn.0253-9934.2007.12.006

2007-01-01

Abstract:Objective To evaluate the efficacy and safety of hemodialysis with regional citrate anticoagulation (RCA),low-molecular-weight heparin(LMWH),and heparin-free hemodialysis in patients at high risk of bleed- ing.Methods Totally 134 patients on hemodialysis were randomized into 3 groups according to the anticoagulation protocols,namely group A with 69 sessions using 30% RCA,group B with 67 sessions of heparin-free hemodialy- sis,and group C with 65 sessions using LMWH as the anticoagulant.The incidence of bleeding,extracorporeal coa- gulation,dialytic efficacy,and blood gas and electrolyte changes were recorded after the sessions.Results All pa- tients in groups A completed the dialysis sessions uneventfully without occurrence of bleeding.In group B,6 ses- sions were terminated due toⅢdegree extracorporeai coagulation.Bleeding or aggravation of the preexisting he- morrhagic condition occurred in 7 patients in group C,and 6 of them withdrew.KT/V in group A was significantly higher than that in group B(P0.01),but similar to that in group C(P0.05).A significant reduction in serum Ca~(2+) was noted after dialysis in group A(P0.05)accompanied by a marked increase in serum HCO_3~- level (but within the normal range,P0.01).The serum levels of Ca~(2+),Ca,Na~+,pH and HCO_3~- remained stable in groups B and C(P0.05).Conclusion RCA is a safer and more effective option for hemodialysis in patients at high risk of bleeding.Heparin-free hemodialysis may cause extracorporeal coagulation,and LMWH should be used with caution in these patients for the potential risk of bleeding.